INTRODUCTION {#h0.0}
============

During their life cycle, bacteria must adapt to several environments. To cope with environments containing few nutrients, Gram-negative bacteria have selected efficient transport systems with TonB-dependent transporters (TBDTs) for nutrient uptake through the outer membrane. Originally identified for its role in high-affinity transport of cobalamin and iron-siderophore complexes ([@B1]), the TonB machinery, consisting of three inner membrane energy-coupling TonB-ExbB-ExbD proteins and TBDT proteins, is now known for its role in uptake of a large variety of substrates, such as carbohydrates and organic acids ([@B2][@B3][@B10]). In marine environments, TBDTs are the dominant membrane proteins identified ([@B11]) and are associated with adaptation of bacteria populations to the phytoplankton blooms ([@B12]). In human gut symbiont *Bacteroides* species, TBDTs interact with carbohydrate-binding proteins and therefore participate in the binding of substrates to the outer membrane ([@B13]). In *Xanthomonas campestris* pv. *campestris*, the causal agent of black rot disease in *Brassica* plants ([@B14]), SuxA TBDT, which is involved in sucrose uptake, is an important pathogenicity determinant ([@B4]).

Surveys of TBDT genes present in sequenced bacterial genomes have shown that around 70% contain 1 to 15 TBDT genes, whereas around 15% possess more than 30 TBDT genes ([@B4], [@B15]). Bacteria displaying TBDT overrepresentation all have the ability to exploit complex carbohydrates ([@B4]). Among these, *Bacteroides thetaiotaomicron* adapts the expression of TBDT and degradative enzyme genes to forage either polysaccharides from the diet or host mucus glycans ([@B16]). Interestingly, genes coding for TBDTs involved in carbohydrate or polysaccharide utilization are often linked to genes required for sensing, binding, degradation, and transport through the bacterial envelope. These genetic loci have been termed carbohydrate utilization loci containing TBDT (CUT) in *X. campestris* pv. *campestris* ([@B4]) and polysaccharide utilization loci (PUL) in *Bacteroides* species ([@B17]).

In *X. campestris* pv. *campestris*, we previously identified and characterized a CUT system devoted to the exploitation of *N*-acetylglucosamine (GlcNAc) ([@B8]). This system comprises genes coding for (i) a cytoplasmic pathway with NagA, NagB-II, NagK-IIA, and NagK-IIB enzymes, which are involved in GlcNAc catabolism; (ii) the transcriptional repressors NagQ and NagR; (iii) the GlcNAc inner membrane transporter NagP; and (iv) four TBDTs (NixA, -B, -C, and -D \[*N*-acetylglucosamine [i]{.ul}nduced in *Xanthomonas*\]) ([@B8]) ([Fig. 1A](#fig1){ref-type="fig"}). Expression of all genes belonging to this CUT system is induced in the presence of GlcNAc through NagQ and NagR inactivation ([@B8]). Although the expression of Nix TBDTs is under the control of GlcNAc, single mutants are not altered in GlcNAc uptake, indicating that none of these transporters is a major GlcNAc transporter ([@B8]).

![Schematic representation of the proposed *N*-acetylglucosamine (GlcNAc) utilization pathway in *X. campestris* pv. *campestris*. (A) Wild-type strain. (B) Δ*nagA* mutant. The *nagA* phenotype is illustrated, i.e., sensitivity to GlcNAc due to accumulation of GlcNAc-6P, which is toxic for *X. campestris* pv. *campestris*. (C) Δ*nagA* Δ*nagP* double mutant. This mutant displays epistasis---loss of sensitivity of the Δ*nagA* mutant due to a secondary mutation in a gene coding for a protein located upstream in the GlcNAc utilization pathway. There is no accumulation of GlcNAc-6P. In this example, the secondary mutation (Δ*nagP*) leads to the nontoxic accumulation of GlcNAc in the periplasm (PP). GlcN, glucosamine; Fru, fructose; OM, outer membrane; IM, inner membrane; TBDT, TonB-dependent transporter; Nix, *N*-acetylglucosamine induced in *Xanthomonas*.](mbo0051419830001){#fig1}

*X. campestris* pv. *campestris* strains with mutations in the GlcNAc deacetylase gene *nagA* display impairment in growth in the presence of GlcNAc ([@B8]). This GlcNAc sensitivity phenotype (or *nagA* phenotype), previously observed in *Escherichia coli* and defined as an inhibition of growth by GlcNAc even in the presence of other carbon sources, is probably due to GlcNAc-6P accumulation ([Fig. 1B](#fig1){ref-type="fig"}) ([@B18], [@B19]). Deletion of either the inner membrane transporter gene (*nagP*) or the two GlcNAc kinase genes (*nagK-IIA* and *nagK-IIB*) is epistatic to this sensitivity *in vitro* ([@B8]). Indeed, these genes are located upstream of *nagA* in the GlcNAc utilization pathway and lead to the nontoxic accumulation of GlcNAc in the periplasm or inside the bacterial cell (see [Fig. 1C](#fig1){ref-type="fig"} for epistasis by deletion of *nagP*). Therefore, in this context, epistasis on *nagA* mutants can be defined as the loss of GlcNAc sensitivity due to the blocking of the GlcNAc utilization pathway upstream of NagA, leading to the absence of entry of GlcNAc into the cell or to the accumulation of a nontoxic compound (no accumulation of GlcNAc-6P).

GlcNAc has important structural roles as the monomer unit of chitin which composes the exoskeleton of crustaceans and insects and the cell wall of fungi. It is also a key component of bacterial cell wall peptidoglycan and of the extracellular matrix of animal cells. In addition to these structural roles, GlcNAc is important for protein function and location in both mammals and plants as a constituent of *N*- and *O*-glycans of glycosylated proteins and is also involved in cell signaling ([@B20]). Despite its central role, to our knowledge, GlcNAc was never considered as a putative substrate that could be exploited by phytopathogenic bacteria during infection of host plants. Given the presence of the CUT system in *X. campestris* pv. *campestris*, we investigated whether this pathogen does indeed take advantage of GlcNAc during infection. By using the GlcNAc-sensitive Δ*nagA* mutant and performing epistasis experiments, we indirectly showed that Nix TBDTs are involved in specific uptake of GlcNAc-containing molecules derived from the plant, from the bacterium, and from other organisms present in the plant environment, such as insects or fungi. We also identified a cluster of genes coding for glycoside hydrolases that are predicted to be involved in *N*-glycan degradation, suggesting that the origin of plant GlcNAc could be *N*-glycans from plant *N*-glycoproteins.

RESULTS {#h1}
=======

A GlcNAc-sensitive Δ*nagA* mutant is altered in pathogenicity. {#h1.1}
--------------------------------------------------------------

Deletion mutants of genes belonging to the GlcNAc CUT system were tested for pathogenicity by wound inoculation on the susceptible plant *Arabidopsis thaliana* ecotype Sf-2 ([Fig. 2A and B](#fig2){ref-type="fig"}; also, see [Table S1](#tabS1){ref-type="supplementary-material"} in the supplemental material). Symptoms were analyzed by scoring disease index (from 0 \[no symptoms\] to 4 \[leaf death\]), and results were given as the percentage of the value for the reference strain at 8 days postinoculation (dpi). Surprisingly, the *nagA* deletion mutant (Δ*nagA* strain) was affected in disease development with around 5 to 10% of symptom intensity retained compared to the wild-type (wt) strain. Complementation of *nagA* deletion by expression of *nagA* in *trans* on a plasmid (pC-*nagA*) restored symptom development ([Fig. 2A and B](#fig2){ref-type="fig"}).

![The *X. campestris* pv. *campestris* Δ*nagA* mutant is altered in pathogenicity on *Arabidopsis thaliana* and during growth in xylem sap from cabbage. *X. campestris* pv. *campestris* strains (OD~600~ = 0.05) were inoculated onto *A. thaliana* ecotype Sf-2 leaves by piercing. (A) Disease index scored at 8 dpi (days postinoculation) and presented as a percentage of the value for the wild-type (wt) strain. Standard deviations were obtained from at least 16 inoculated leaves from four plants. Values significantly different (*P* \< 0.0001) from those for the wt strain (a) and the Δ*nagA* mutant (b) are indicated. (B) Black rot symptoms observed on leaves at 8 dpi. (C) IGC in the inoculated area. Bacteria were extracted from inoculated leaves at different dpi and counted by plating serial dilutions. Results are given as CFU per cm^[@B2]^ of leaves. Standard deviations were obtained from at least 3 independent samples. (D) Growth of *X. campestris* pv. *campestris* strains in xylem sap from *Brassica oleracea* cv. Bartolo F1 cabbages (OD~600~ = 0.01 at time zero). At different time points, CFU were counted by plating serial dilutions. Standard deviations were obtained from at least 3 independent experiments.](mbo0051419830002){#fig2}

Deletion of *nagQ*, *nagP*, *nagR*, or *nagK-IIAB* did not significantly affect disease development, suggesting that on its own, the GlcNAc utilization pathway is not required for symptom development. The Δ*nagQ-nagA* mutant, which contains deletions of *nagQ*, *nagP*, *nagR*, *nagB-II*, and *nagA*, was also not altered in pathogenicity ([Fig. 2A](#fig2){ref-type="fig"}), suggesting that the pathogenicity phenotype observed for *nagA* mutants is intrinsic to *nagA* and probably linked to GlcNAc sensitivity. This was confirmed by deletion of *nagP* or *nagK-IIAB* in the Δ*nagA* background. Indeed, these deletions restored disease development on *A. thaliana* ([Fig. 2A](#fig2){ref-type="fig"}; also, see [Table S1](#tabS1){ref-type="supplementary-material"} in the supplemental material). Therefore, the inner membrane transporter and the two GlcNAc kinases, which are located upstream of NagA in the GlcNAc utilization pathway ([Fig. 1](#fig1){ref-type="fig"}), are epistatic to the phenotype observed for the *nagA* mutant *in planta*. This suggests that the absence of symptoms observed for the Δ*nagA* strain reflects sensitivity to GlcNAc and/or GlcNAc-containing molecules encountered *in planta* during the infection process. In regard to substrate specificities of both NagP and GlcNAc kinases (NagK-IIA and NagK-IIB) ([@B8]), sensitivity observed for the Δ*nagA* strain is probably not due to another compound that could be present *in planta*.

Population size of the Δ*nagA* strain *in planta* decreased after inoculation compared to that of the wt strain ([Fig. 2C](#fig2){ref-type="fig"}). After 7 days, the population size obtained for the Δ*nagA* mutant was around 150 times lower than that of wt strain. Growth was restored when *nagA* was supplemented in *trans* with the plasmid pC-*nagA*.

Growth of the Δ*nagA* mutant is altered in xylem sap. {#h1.2}
-----------------------------------------------------

*X. campestris* pv. *campestris* is a bacterium that enters and colonizes xylem vessels through leaf wounds or hydathodes ([@B21]). A recent analysis of *X. campestris* pv. *campestris* adaptation to xylem sap (XS) from *Brassica oleracea* cv. Bartolo F1 cabbages demonstrate that XS is a good tool to study *in vitro* early infection steps ([@B22]). We therefore checked whether GlcNAc encountered by *X. campestris* pv. *campestris* during infection could be found in XS by analyzing the GlcNAc sensitivity phenotype of the Δ*nagA* mutant grown in XS ([Fig. 2D](#fig2){ref-type="fig"}; also, see [Table S2](#tabS2){ref-type="supplementary-material"} in the supplemental material). Compared to the wt strain, growth of the Δ*nagA* mutant was significantly impaired after transfer into XS. Deletion of either *nagP* or *nagK-IIAB* in the Δ*nagA* background restored growth to levels equivalent or close to those reached by the wt strain. This epistatic effect suggests that the phenotype observed for *nagA* mutants in XS is probably due to GlcNAc sensitivity.

Interestingly, GC-MS analysis of XS compounds did not allow the identification of free GlcNAc ([@B22]), suggesting that if GlcNAc is present in XS, the free GlcNAc concentration is below 1 µM. Sensitivity to GlcNAc of the Δ*nagA* strain is observed for concentrations above 5 µM ([@B8]). Therefore, sensitivity observed during growth in XS is probably due not to free GlcNAc but rather to GlcNAc-containing complex molecules.

GlcNAc is generated during stationary growth phase. {#h1.3}
---------------------------------------------------

To investigate whether GlcNAc sensitivity observed *in planta* and in XS was due at least in part to GlcNAc that originates from the bacterium, we analyzed the survival of the Δ*nagA* mutant grown in minimal medium for 48 h ([Fig. 3](#fig3){ref-type="fig"}). To compare *X. campestris* pv. *campestris* growth in XS with growth in minimal medium, we developed MMC minimal medium (0.5% Casamino Acids), which is derived from MME minimal medium (0.15% Casamino Acids). In MMC medium, log phase and entry into stationary phase are comparable to what is observed during growth in XS (data not shown). Therefore, MMC minimal medium was used to study epistasis during the different growth phases.

![Growth of the *X. campestris* pv. *campestris* Δ*nagA* mutant is altered at the entry into stationary phase. *X. campestris* pv. *campestris* strains (OD~600~ = 0.1 at time zero) were grown in MMC minimal medium for 48 h at 30°C. At different time points, bacterial populations were measured by plating serial dilutions, and results are given as log CFU/ml. Standard deviations were obtained from at least three independent experiments. Values significantly different (*P* \< 0.0001) from those for the wt strain (a) and both the wt and Δ*nagA* strains (b) are indicated.](mbo0051419830003){#fig3}

Between 3 and 9 h of growth in MMC minimal medium (log phase), Δ*nagA* and wt strains showed similar growth. This result suggests that during these first 9 h of growth, the Δ*nagA* strain does not display GlcNAc sensitivity in this medium. Therefore, sensitivity observed from 6 h in XS is probably due to GlcNAc-containing molecules that are specific to the plant. In contrast, from 24 to 48 h, when growth of the wt strain slows down (stationary phase), the Δ*nagA* mutant displayed a significant decrease in bacterial population. Mutation of either *nagP* or *nagK-IIAB* in Δ*nagA* background restored growth suggesting a link between the phenotype observed for the Δ*nagA* mutant during growth *in vitro* and GlcNAc. The MMC minimal medium used in these experiments contains no GlcNAc (see Materials and Methods). Therefore, we can speculate that GlcNAc, which could be responsible for the decrease in the bacterial population observed for the Δ*nagA* strain from 24 h of growth in MMC minimal medium, may originate from the bacterium.

In *X. campestris* pv. *campestris*, GlcNAc is a major component of the peptidoglycan (PG) ([@B23]), and in *E. coli* and probably in other Gram-negative bacteria, almost 50% of the PG is broken down and recycled at each generation ([@B24], [@B25]). In *E. coli*, PG degradation products, i.e., anhydromuropeptides, are transported across the inner membrane into the cytoplasm via AmpG permease ([@B25], [@B26]). A protein showing homology to AmpG is encoded in *X. campestris* pv. *campestris* by *XCC3845* (34% identity and 52% similarity at the amino acid level with the *E. coli* AmpG permease). In contrast, *X. campestris* pv. *campestris* does not encode homologs of other transporters of PG recycling products in *E. coli* (MurP, MppA, and Opp \[[@B27]\]). We therefore analyzed the role of *X. campestris* pv. *campestris* AmpG in the uptake of bacterium-derived GlcNAc-containing molecules by performing epistasis experiments on the Δ*nagA* mutant during growth in MMC minimal medium. Interestingly, bacterial growth of the *X. campestris* pv. *campestris* Δ*nagA ampG*\*I double mutant in MMC minimal medium was comparable to the growth observed for the wt strain up to 24 h ([Fig. 3](#fig3){ref-type="fig"}), suggesting that from 9 to 24 h (entry into stationary phase), *ampG* is epistatic to *nagA* in MMC minimal medium. Therefore, at least part of the GlcNAc sensitivity observed *in vitro* in minimal medium is due to GlcNAc-containing molecules transported by AmpG and thus probably generated during PG recycling. At 48 h, *ampG* was partially epistatic to *nagA*, suggesting that at this time point, bacterium-derived GlcNAc is probably at least in part transported through another inner membrane transporter.

PG recycling cannot completely explain the *in planta* phenotype of *nagA* mutants. {#h1.4}
-----------------------------------------------------------------------------------

As described above, AmpG is proposed to be involved in PG recycling in *X. campestris* pv. *campestris*. To check whether PG recycling could be responsible for the release of GlcNAc *in planta* or during growth in XS, we analyzed the epistasis of the AmpG permease to the *nagA* phenotype under both sets of conditions. Surprisingly, disease index and growth in XS were similar for Δ*nagA ampG*\*I and Δ*nagA* mutants, suggesting that AmpG was not epistatic *in planta* and during growth in XS ([Fig. 2A and D](#fig2){ref-type="fig"}, respectively). However, bacterial population densities observed *in planta* suggest that AmpG was at least partially epistatic ([Fig. 2C](#fig2){ref-type="fig"}). These results indirectly suggest that although part of the GlcNAc sensitivity observed *in planta* could be attributed to bacterium-derived GlcNAc, i.e., peptidoglycan recycling, it cannot completely explain the phenotypes of the Δ*nagA* mutant observed *in planta* and in XS.

The *nagA* phenotype observed *in planta* probably reflects an addition of sensitivity to GlcNAc molecules that originate from different compounds. Mutation of *ampG* is presumed to limit entry of only bacterium-derived GlcNAc-containing molecules from PG, and therefore, *in planta* or during growth in XS, GlcNAc-containing molecules from other origins could still induce sensitivity. Conversely, during growth in minimal medium, sensitivity is due only to bacterium-derived GlcNAc-containing molecules, and mutation of *ampG* would abolish entry of the main source of GlcNAc-containing molecules. This could explain epistasis observed with *ampG in vitro*, whereas almost no epistasis was observed *in planta* or during growth in XS.

Nix TBDTs are epistatic to the *nagA* phenotype *in planta* and during growth in XS. {#h1.5}
------------------------------------------------------------------------------------

Individual and multiple deletions of the four *nix* TBDT genes did not affect pathogenicity of the strain (see [Table S1A](#tabS1){ref-type="supplementary-material"} in the supplemental material). However, the quadruple deletion mutant in the Δ*nagA* background led to an epistasis *in planta*, as symptoms were partially restored ([Fig. 4A](#fig4){ref-type="fig"}) and bacterial growth was nearly restored in *Arabidopsis* ([Fig. 4B](#fig4){ref-type="fig"}). Similarly, an important epistasis was observed during growth in XS from cabbages ([Fig. 4C](#fig4){ref-type="fig"}). Interestingly, \[^14^C\]GlcNAc transport was not affected in the Δ*nixABCD* mutant compared to the wt strain ([Table 1](#tab1){ref-type="table"}), and *nix* TBDTs were not epistatic to the *nagA* sensitivity phenotype when the strain was grown in minimal medium containing free GlcNAc (see [Table S3](#tabS3){ref-type="supplementary-material"} in the supplemental material). These results suggest that Nix TBDTs are involved in the uptake not of free GlcNAc but rather of GlcNAc-containing complex molecules.

![Nix TonB-dependent transporters of *X. campestris* pv. *campestris* are epistatic to the *nagA* phenotype during plant infection and growth in cabbage xylem sap. (A and B) *X. campestris* pv. *campestris* strains (OD~600~ = 0.05) were inoculated onto leaves of *Arabidopsis thaliana* Sf-2 ecotype by piercing. (A) Disease index scored at 8 days postinoculation (dpi), presented as percentages of the value for the wt strain (gray) or the *ampG*\*I strain (white). Standard deviations were obtained from at least 16 leaves from 4 plants. Values significantly different (*P* value \<0.0001) from those for the wt strain (a; sensitivity), both the wt and Δ*nagA* strains (b; partial epistasis), the *ampG*\*I strain (c; sensitivity), the Δ*nagA ampG*\*I and *ampG*\*I strains (d; partial epistasis), and the Δ*nagA ampG*\*I strain (e; total epistasis) are indicated. (B) IGC in the inoculated area. Bacteria were extracted from infected leaves at different dpi and counted by plating serial dilutions. Standard deviations were obtained from at least 3 independent samples. (C) Epistasis on the Δ*nagA* mutant during growth in xylem sap from *Brassica oleracea* cv. Bartolo F1 cabbages (OD~600~ = 0.01 at time zero). At different time points, CFU were counted by plating serial dilutions. Maximal specific growth rates (µ~max~) were calculated between 3 and 9 h of growth from CFU counts. Standard deviations were obtained from at least three independent experiments. Values significantly different (*P* \< 0.0001) from those for the wt strain (a; sensitivity), both the wt and Δ*nagA* strains (b; partial epistasis), and the Δ*nagA* strain (c; total epistasis) are indicated.](mbo0051419830004){#fig4}

###### 

Rates of ^14^C-labeled-*N*-acetylglucosamine transport in *X. campestris* pv. *campestris* mutants compared to the wild-type (wt) strain^[*a*](#ngtab1.1)^

  Strain genotype   Gene ID     Transport (% of wt)^[*b*](#ngtab1.2)^
  ----------------- ----------- ---------------------------------------
  wt                            100.0 ± 10.1
  Δ*nixA*           *XCC3408*   84.6 ± 9.1
  Δ*nixB*           *XCC0531*   91.4 ± 2.9
  Δ*nixC*           *XCC2944*   91.6 ± 4.7
  Δ*nixD*           *XCC2887*   94.0 ± 5.5
  Δ*nixABCD*                    90.4 ± 5.6

Transport rates were measured 60 min after addition of ^14^C-labeled *N*-acetylglucosamine.

Values are means and standard deviations, which were calculated from six independent experiments.

Single deletions of *nix* TBDT genes were not epistatic to the *nagA* phenotype (see [Table S1B](#tabS1){ref-type="supplementary-material"} in the supplemental material). Interestingly, among double and triple deletion mutants, only deletions containing *nixD* (i.e., Δ*nixAD*, Δ*nixBD*, Δ*nixCD*, Δ*nixABD*, Δ*nixACD*, and Δ*nixBCD* mutants) resulted in partial epistasis on the *nagA* phenotype. Conversely, no epistasis was observed with the Δ*nixAB*, Δ*nixAC*, Δ*nixBC*, and Δ*nixABC* mutants ([Fig. 4A](#fig4){ref-type="fig"}; also, see [Table S1B](#tabS1){ref-type="supplementary-material"} in the supplemental material). Therefore, NixD seems to play a major role in the uptake of GlcNAc-containing molecules *in planta*. Similarly, in the Δ*nagA ampG*\*I background, partial epistasis was observed when *nixD* was deleted ([Fig. 4A](#fig4){ref-type="fig"}), and almost total epistasis was observed when both *nixA* and *nixD* were deleted (see [Table S1D](#tabS1){ref-type="supplementary-material"} in the supplemental material), suggesting that NixA also participates in the uptake of GlcNAc-containing molecules *in planta*.

In XS, partial epistasis on the Δ*nagA* mutant was observed when *nixD* was deleted ([Fig. 4C](#fig4){ref-type="fig"}), and epistasis was complete when either *nixA*, *nixB*, or *nixC* was deleted in the Δ*nixD* mutant (Δ*nixAD*, -*BD*, and -*CD* in the Δ*nagA* background) (see [Table S2](#tabS2){ref-type="supplementary-material"} in the supplemental material) suggesting that in XS, in addition to NixD, NixA, -B, and -C also contribute to the uptake of GlcNAc-containing molecules.

NixC is epistatic to the *nagA* phenotype upon entry into stationary phase. {#h1.6}
---------------------------------------------------------------------------

As described above, there is indirect evidence that Nix TBDTs are involved in the uptake of GlcNAc-containing molecules during infection. These molecules could at least in part originate from bacterial PG recycling. Therefore, we analyzed the role of each Nix TBDT in the uptake of GlcNAc-containing molecules during entry into stationary phase by performing epistasis experiments during growth in MMC minimal medium. Interestingly, upon entry into stationary phase, epistasis on the Δ*nagA* strain was complete when *nixC* was deleted ([Fig. 5A](#fig5){ref-type="fig"}), whereas no epistasis was observed when *nixA*, *nixB*, and *nixD* were deleted individually (data not shown) or simultaneously ([Fig. 5A](#fig5){ref-type="fig"}). This suggests that NixC plays a major role in the uptake of GlcNAc-containing molecules derived from the bacterium.

![The *X. campestris* pv. *campestris* TonB-dependent transporter NixC is epistatic to the *nagA* phenotype during growth in MMC minimal medium and with NixD is involved in chitooligosaccharide uptake. (A) Epistasis on the Δ*nagA* mutant during growth in MMC minimal medium. Bacterial populations were measured by plating serial dilutions, and results are given as log CFU/ml. Standard deviations were obtained from at least three independent experiments. Values significantly different (*P* \< 0.0001) from that of the wt strain (a; sensitivity) are indicated. (B) Growth of *X. campestris* pv. *campestris* strains in MME minimal medium containing *N*-acetylglucosamine (GlcNAc) or chitohexaose (CHI-6) at 0.1% (wt/vol). Results are given as maximal specific growth rates (µ~max~) relative to the wild-type (wt) strain. Specific µ~max~ were calculated during the log phase of the wt strain in GlcNAc-containing medium (between 7 and 12 h) based on OD~600~ values. Standard deviations were obtained from at least three independent experiments. Values significantly different (*P* \< 0.0001) from that of the wt strain (a) and both the wt and Δ*nixABCD* strains (b) are indicated. (C) Epistasis on the Δ*nagA* mutant during growth in MMC minimal medium or MMC containing chitohexaose at 100 µM (MMC + CHI-6). Results are given as specific µ~max~ relative to the wt strain. Specific µ~max~ were calculated between 3 and 9 h of growth from CFU counts. Standard deviations were obtained from at least three independent experiments. Values significantly different (*P* \< 0.0001) from that of the wt strain (a; sensitivity) and the Δ*nagA* strain (b; total epistasis) are indicated.](mbo0051419830005){#fig5}

NixC and NixD are involved in the uptake of chitooligosaccharides. {#h1.7}
------------------------------------------------------------------

In the environment, chitin constitutes a natural source of GlcNAc for chitinolytic bacteria ([@B28], [@B29]). *X. campestris* pv. *campestris* is not chitinolytic ([@B8]), but it is able to use chitooligosaccharides (CHI) from a degree of polymerization of 2 (CHI-2; chitobiose) ([@B8]) to one of 6 (CHI-6; chitohexaose) (see [Table S4A](#tabS4){ref-type="supplementary-material"} in the supplemental material). NagP and NagKII-AB proteins are involved in chitooligosaccharide utilization, as strains with mutations in the corresponding genes had altered growth on these substrates (see [Table S4B](#tabS4){ref-type="supplementary-material"} in the supplemental material). Growth of the Δ*nixABCD* strain on chitooligosaccharides was impaired ([Fig. 5B](#fig5){ref-type="fig"}; also, see [Table S4](#tabS4){ref-type="supplementary-material"}), suggesting that Nix TBDTs are involved in the uptake of chitooligosaccharides. Deletion of *nixA* or *nixB* did not affect growth with any of the tested chitooligosaccharides (see [Table S4A](#tabS4){ref-type="supplementary-material"}), and reintroduction of either *nixA* or *nixB* into the genome failed to complement the Δ*nixABCD* strain (see [Table S4B](#tabS4){ref-type="supplementary-material"}). We observed a slight reduction of growth for the Δ*nixD* mutant on all chitooligosaccharides tested ([Fig. 5B](#fig5){ref-type="fig"}; also, see [Table S4A](#tabS4){ref-type="supplementary-material"}), and growth was complemented when *nixD* was reintroduced in the Δ*nixABCD* mutant (see [Table S4B](#tabS4){ref-type="supplementary-material"}). Interestingly, the Δ*nixC* mutant exhibited a significant growth defect on chitohexaose (CHI-6) ([Fig. 5B](#fig5){ref-type="fig"}) but not other chitooligosaccharides (see [Table S4A](#tabS4){ref-type="supplementary-material"}). However, growth of the Δ*nixABCD* strain in the presence of the tested chitooligosaccharides was restored when *nixC* was reintroduced in the genome (see [Table S4B](#tabS4){ref-type="supplementary-material"}, data for the Δ*nixABCD* Cp^chr^-*nixC* strain). This suggests that the absence of phenotype for Δ*nixC* on CHI-2 to CHI-5 is due to functional redundancy with *nixD*. These results were confirmed by epistasis experiments using the Δ*nagA* mutant during growth in the presence of chitooligosaccharides. Indeed, among single-deletion mutants, only *nixC* was epistatic to *nagA* on chitohexaose ([Fig. 5C](#fig5){ref-type="fig"}; also, see [Table S2](#tabS2){ref-type="supplementary-material"}). Therefore, both NixC and NixD transport chitooligosaccharides ranging from CHI-2 to CHI-6, but NixC seems to be the major transporter of large molecules (CHI-6).

Altogether, these results are consistent with the idea that NixC is the primary transporter of bacterium-derived GlcNAc-containing molecules and large chitooligosaccharides. NixD also contributes to chitooligosaccharide uptake, whereas neither NixA nor NixB is involved in bacterium-derived GlcNAc-containing molecules and chitooligosaccharide transport. In contrast, during the infection process *in planta* and during growth in XS, GlcNAc-containing molecules are mainly transported via NixD with a contribution of NixA. NixB and NixC also participate in the uptake of GlcNAc-containing molecules during growth in XS. This specific uptake profile observed for Nix TBDTs suggests that at least part of the GlcNAc-containing molecules encountered *in planta* and in XS are different from bacterium-derived and chitooligosaccharide molecules and are probably plant-specific GlcNAc-containing molecules.

Plant-specific GlcNAc-containing molecules could be *N*-glycans from plant *N*-glycoproteins. {#h1.8}
---------------------------------------------------------------------------------------------

We identified genes coding for several glycoside hydrolases (*XCC2888* to *XCC2895*) ([Fig. 6A](#fig6){ref-type="fig"}) downstream of and in the same orientation as *nixD* (*XCC2887*). These genes belong to the GlcNAc and NagR regulons, as determined by their expression profile. Indeed, the expression of *XCC2888* to *XCC2895* and of *XCC2888* to *XCC2891* was induced in the presence of GlcNAc and in a Δ*nagR* background, respectively ([Table 2](#tab2){ref-type="table"}). Consequently, these genes were renamed *nixE* to *nixL*, in accordance with the nomenclature of *nix* TBDT genes ([@B8]). Furthermore, the expression profiles of these genes in *nixD*, *nixE*, *nixG*, and *nixI* pVO155 polar insertion mutants (see [Fig. S1](#figS1){ref-type="supplementary-material"} in the supplemental material) suggest that *nixD* to *nixL* form an operon with a putative promoter localized upstream of *nixG*. Indeed, a residual expression of genes *nixG* to *nixL* was detected in the *nixD*\*I and *nixE*\*I mutants, which was lost in the *nixG*\*I and *nixI*\*I mutants (see [Fig. S1](#figS1){ref-type="supplementary-material"}).

![*N*-Glycans from plant *N*-glycosylated proteins can be substrates for Nix glycoside hydrolases encoded by the *X. campestris* pv. *campestris N*-glycan cluster. (A) Genetic organization of genes belonging to the *N*-glycan cluster. Black arrows indicate transcription start sites. The dashed black arrow represents a putative transcription start identified in this study. TBDT, TonB-dependent transporter. (B) Proposed cleavage sites by Nix enzymes encoded by the *N*-glycan cluster on a plant complex-type *N*-glycan with Lewis^a^ epitopes. Residues conserved in all *N*-glycans are in black, residues found in all complex-type *N*-glycans are in gray, and residues specific to complex-type *N*-glycans with Lewis^a^ epitopes are in white. Cleavage sites proposed in the KEGG pathway database (<http://www.genome.jp/kegg-bin/show_pathway?org_name=xcc&mapno=00511&mapscale=&show_description=show>) are depicted by solid arrows, whereas cleavage sites proposed in the present study are depicted by dotted arrows. Fuc, fucose; Gal, galactose; Man, mannose; NAG, *N*-acetylglucosamine; Xyl, xylose.](mbo0051419830006){#fig6}

###### 

Relative expression ratios of *X. campestris* pv. *campestris nixE* to *nixL* and *aspG* genes^[*a*](#ngtab2.1)^

  Gene ID     Gene name   Expression ratio (mean ± SD)    
  ----------- ----------- ------------------------------- -------------------------------
  *XCC2888*   *nixE*      77 ± 24^[*b*](#ngtab2.2)^       31.6 ± 9.75^[*b*](#ngtab2.2)^
  *XCC2889*   *nixF*      50.3 ± 19.8^[*b*](#ngtab2.2)^   23.8 ± 2.5^[*b*](#ngtab2.2)^
  *XCC2890*   *nixG*      4.36 ± 1.02^[*b*](#ngtab2.2)^   2.8 ± 1.3^[*b*](#ngtab2.2)^
  *XCC2891*   *nixH*      3.04 ± 0.4^[*b*](#ngtab2.2)^    2.1 ± 0.2^[*b*](#ngtab2.2)^
  *XCC2892*   *nixI*      6.64 ± 0.88^[*b*](#ngtab2.2)^   2.57 ± 0.99
  *XCC2893*   *nixJ*      2.72 ± 1.4                      0.95 ± 0.26
  *XCC2894*   *nixK*      3.17 ± 0.7^[*b*](#ngtab2.2)^    1.6 ± 0.5
  *XCC2895*   *nixL*      3.64 ± 0.55^[*b*](#ngtab2.2)^   1.76 ± 0.7
  *XCC2914*   *aspG*      1 ± 0.01                        0.9 ± 0.3

From real-time quantitative reverse transcriptase PCR performed in at least three independent experiments. Calculation of relative expression includes normalization against the 16S rRNA endogenous control gene. MME, minimal medium; GlcNAc, *N*-acetylglucosamine; wt: wild type.

The levels of expression under the conditions compared were significantly different (*P* \< 0.05).

The putative function of NixE to NixL glycoside hydrolases is indicated in [Fig. 6A](#fig6){ref-type="fig"}. The KEGG pathway database proposes that the putative α-[l]{.smallcaps}-fucosidase (NixE), β-hexosaminidase (NixG), β-mannosidase (NixH), and asparaginase (AspG/XCC2914, which does not belong to the GlcNAc regulon, as determined by qRT-PCR) ([Table 2](#tab2){ref-type="table"}) cleave glycosidic bonds found in *N*-glycans of *N*-glycoproteins ([Fig. 6B](#fig6){ref-type="fig"}). Furthermore, *nixF* encodes an enzyme with a putative chitinase and/or endo-β-*N*-acetylglucosaminidase activity. *X. campestris* pv. *campestris* strain ATCC 33913 is not able to use chitin as a carbon source ([@B8]), but this enzyme could be involved in the endohydrolysis of the *N*,*N*′-diacetylchitobiosyl units found in all *N*-glycans ([Fig. 6B](#fig6){ref-type="fig"}). *nixK* and *nixJ* encode putative α-mannosidases potentially involved in the cleavage of α-glycosidic bonds between two mannose residues. *nixL* codes for a β-galactosidase that could cleave terminal galactose residues found in some complex *N*-glycans ([Fig. 6B](#fig6){ref-type="fig"}). Finally, *nixI* encodes a protein belonging to the GH-3 family, which includes β-glucosidases. Its role in *N*-glycan degradation could not be determined. All these proteins possess a signal peptide, suggesting that they are all translocated through the inner membrane to the periplasm and/or to the extracellular environment. NixL is probably not secreted, as no β-galactosidase activity was detected in the culture supernatant of *X. campestris* pv. *campestris* strain Xc17 ([@B30]).

To distinguish between the locus comprising *nag* genes (GlcNAc cluster \[[@B8]\]) involved in GlcNAc catabolism and the locus of *nix* enzyme genes potentially involved in *N*-glycan degradation, we named the locus from *nixE* to *nixL* the *N*-glycan cluster ([Fig. 6A](#fig6){ref-type="fig"}).

Nix enzymes seem to participate in the release of GlcNAc *in planta*. {#h1.9}
---------------------------------------------------------------------

Similar to what is observed for the GlcNAc cluster, deletion of the entire *N*-glycan cluster did not affect the capacity of the strain to develop symptoms on *A. thaliana* ([Fig. 7A](#fig7){ref-type="fig"}), meaning that these enzymes are not important for disease symptoms under the tested conditions. To test whether the *N*-glycan cluster could participate in the consumption of GlcNAc-containing molecules *in planta*, we performed epistasis experiments on strains with the *nagA* phenotype. During plant infection, no epistasis on disease development was observed for the Δ*nagA* Δ*nixE-nixL* mutant ([Fig. 7A](#fig7){ref-type="fig"}). However, despite the absence of visible symptoms at 7 dpi (days postinoculation), growth was almost restored ([Fig. 7B](#fig7){ref-type="fig"}), suggesting that partial epistasis occurs. The 0.5-log difference in bacterial population between wt and Δ*nagA* Δ*nixE-nixL* strains at 7 dpi ([Fig. 7B](#fig7){ref-type="fig"}) could explain the difference in the appearance of symptoms ([Fig. 7A](#fig7){ref-type="fig"}). Deletion of this cluster in a Δ*nagA ampG*\*I background (Δ*nagA ampG*\*I Δ*nixE-nixL* strain) partially restored disease symptoms ([Fig. 7A](#fig7){ref-type="fig"}), and insertion of the entire *N*-glycan cluster elsewhere in the chromosome (Δ*nagA ampG*\*I Δ*nixE-nixL* Cp^chr^-*nixE-nixL* complemented strain) restored the sensitivity ([Fig. 7A](#fig7){ref-type="fig"}). It is worth noting that the Δ*nagA ampG*\*I Δ*nixE-nixL* strain was still sensitive to free GlcNAc *in vitro*, as its growth was comparable to the growth observed for the Δ*nagA ampG*\*I mutant in medium containing GlcNAc (see [Table S3](#tabS3){ref-type="supplementary-material"} in the supplemental material). Furthermore, growth of the Δ*nixE-nixL* mutant on GlcNAc was comparable to that of the wt strain, suggesting that none of the enzymes encoded by this cluster play a major role in GlcNAc utilization (see [Table S4](#tabS4){ref-type="supplementary-material"}). Deletion of this cluster partially restored growth of the Δ*nagA* mutant in XS at 24 h ([Fig. 7C](#fig7){ref-type="fig"}), and epistasis in XS was complete in the Δ*nagA ampG*\*I background (see [Table S2](#tabS2){ref-type="supplementary-material"}).

![Nix glycoside hydrolases of *X. campestris* pv. *campestris* are partially epistatic to the *nagA* phenotype during plant infection and growth in cabbage xylem sap. (A and B) *X. campestris* pv. *campestris* strains (OD~600~ = 0.05) were inoculated by piercing leaves of *Arabidopsis thaliana* ecotype Sf-2. (A) Disease index scored at 8 days postinoculation. Results are given as percentages of the value for the wild-type (wt) strain. Standard deviations were obtained from at least 16 inoculated leaves from four plants. (B) IGC for the inoculated area. Results are given as CFU per cm^[@B2]^ of leaves. Standard deviations were obtained from at least 3 independent samples. (C) Growth of *X. campestris* pv. *campestris* strains in xylem sap from *Brassica oleracea* cv. Bartolo F1 cabbage (OD~600~ = 0.01 at time zero). (D) Growth of *X. campestris* pv. *campestris* strains in MME minimal medium containing chitotetraose (0.1% \[wt/vol\]). Standard deviations were obtained from at least three independent experiments. (E) Growth of *X. campestris* pv. *campestris* strains in MMC minimal medium (OD~600~ = 0.1 at time zero). (C and E) At different time points, CFU were counted by plating serial dilutions. Standard deviations were obtained from at least three independent experiments. Values significantly different (*P* \< 0.0001) from that for the wt strain (a), both the wt and Δ*nagA ampG*\*I strains (b), and the Δ*nagA* strain (c) are indicated.](mbo0051419830007){#fig7}

The *N*-glycan cluster participates in chitooligosaccharide utilization, as growth of the Δ*nixE-nixL* mutant was altered on these substrates ([Fig. 7D](#fig7){ref-type="fig"}; also, see [Table S4](#tabS4){ref-type="supplementary-material"} in the supplemental material). However, growth observed was intermediate, suggesting that Nix enzymes only partially contribute to chitooligosaccharide utilization. This could explain the absence of epistasis of *nixE-nixL* on the *nagA* phenotype in the presence of chitooligosaccharides (see [Tables S2 and S3](#tabS2 tabS3){ref-type="supplementary-material"}). Two enzymes encoded by the *N*-glycan cluster could cleave β-*N*-acetylglucosamine links (i.e., NixF and NixG), but only NixG was able to complement bacterial growth of the Δ*nixE-nixL* mutant on chitotetraose ([Fig. 7D](#fig7){ref-type="fig"}) or chitobiose (see [Table S4A](#tabS4){ref-type="supplementary-material"}).

Finally, no significant epistasis of *nixE-nixL* on the *nagA* phenotype was observed during bacterial growth in minimal medium ([Fig. 7E](#fig7){ref-type="fig"}).

The absence of epistasis at the early stationary phase and during growth in the presence of chitooligosaccharides while epistasis was observed both *in planta* and in XS indirectly suggests that enzymes belonging to the *N*-glycan cluster (NixE to NixL) are involved in the release of plant-specific GlcNAc during the infection process and during growth in XS.

DISCUSSION {#h2}
==========

*X. campestris* pv. *campestris*, the causal agent of black rot disease on *Brassica*, produces an extensive repertoire of glycoside hydrolases, lyases, and esterases ([@B31]) that target linkages present in plant cell wall polysaccharides such as cellulose, mannan, xylan, galacturonan, and pectin. Some of these enzymes contribute to pathogenicity by providing nutrients through degradation of plant cell wall polysaccharides and by facilitating bacterial spread in plant tissues ([@B32]). We previously identified in *X. campestris* pv. *campestris* a CUT system devoted to *N*-acetylglucosamine (GlcNAc) utilization ([@B8]). In addition to genes coding for two repressors, an inner membrane transporter, and enzymes involved in GlcNAc catabolism (lower pathway, in red in [Fig. 8](#fig8){ref-type="fig"}), we determined that this CUT system also codes for 4 TBDTs (NixA, -B, -C, and -D) and 8 glycoside hydrolases (NixE to NixL).

![Schematic representation of utilization pathways for *N*-acetylglucosamine (GlcNAc) and GlcNAc-containing molecules in *X. campestris* pv. *campestris*. GlcNAc-containing molecules can originate from bacteria (peptidoglycan degradation products \[orange\]), from insects or fungi (chitooligosaccharides derived from chitin \[blue\]), or from plants (plant-glycosylated substrates \[green\]). The GlcNAc utilization pathway (uptake through NagP and catabolism) is depicted in red. Enzymatic reactions are designated by solid arrows, whereas dashed arrows indicate transport. The Nix TBDT(s) proposed to play a major role in the uptake of specific GlcNAc-containing molecules is indicated. OM, outer membrane; PG, peptidoglycan; PP, periplasm; IM, inner membrane; TBDT, TonB-dependent transporter; GlcN, glucosamine; Fru, fructose; GlcNAc-anhMurNAc, *N*-acetylglucosaminyl-1,6-anhydro-*N*-acetylmuramyl.](mbo0051419830008){#fig8}

GlcNAc-sensitive *nagA* mutants: a tool to study the GlcNAc utilization pathway in *X. campestris* pv. *campestris*. {#h2.1}
--------------------------------------------------------------------------------------------------------------------

As observed for the xylan CUT system ([@B9]), the ability of *X. campestris* pv. *campestris* to metabolize GlcNAc is not required for pathogenicity under the conditions tested. However, mutants in the *nagA* gene coding for the GlcNAc deacetylase are severely impaired in pathogenicity and show a significant decrease in bacterial population due to GlcNAc sensitivity: the presence of GlcNAc or GlcNAc-containing molecules inhibits growth despite the presence of other carbon sources ([Fig. 1B](#fig1){ref-type="fig"}). The *nagA* phenotype was used in this study as a tool to analyze in *X. campestris* pv. *campestris* the GlcNAc utilization pathway upstream of the inner membrane transporter NagP, focusing on the role of Nix TBDT transporters and Nix glycoside hydrolases. GlcNAc has a central role in nature as a component of bacterial and fungal cell walls (peptidoglycan and chitin, respectively), insects and crustacean exoskeletons, and the extracellular matrix of animal cells. However, this molecule is not part of plant cell wall polysaccharide matrix and was never considered as a putative substrate that could be utilized by phytopathogens during infection of host plants. Results obtained in this study suggest that *X. campestris* pv. *campestris* encounters and metabolizes GlcNAc during plant infection and growth in XS. Nix TBDTs are proposed to be involved in the uptake of complex molecules containing GlcNAc derived from the plant, bacteria, fungi, and/or insects, whereas Nix enzymes mainly contribute to the generation of GlcNAc-containing molecules derived from the plant ([Fig. 8](#fig8){ref-type="fig"}).

Besides its usefulness as a tool to study the GlcNAc utilization pathway, the *nagA* phenotype observed in pathogenicity tests could be used like *in vivo* expression technology (IVET) ([@B33]) as a more generalized tool to study expression pattern of a large range of promoters *in planta*. Indeed, it is possible to clone *X. campestris* pv. *campestris* promoters upstream of the *nagA* gene in an expression plasmid. These plasmids could be introduced in a Δ*nagA* strain of *X. campestris* pv. *campestris*, and the resulting strains could be used to perform pathogenicity tests. Only bacteria expressing *nagA* from the plasmid (carrying an active promoter) *in planta* would be able to produce symptoms on plants.

Indirect evidence that GlcNAc is exploited during peptidoglycan catabolism. {#h2.2}
---------------------------------------------------------------------------

When cultured in minimal medium, growth of the *X. campestris* pv. *campestris* ATCC 33913 *nagA* deletion mutant was severely impaired at the early stationary phase ([Fig. 3](#fig3){ref-type="fig"}). We attribute this phenotype to peptidoglycan recycling. Indeed, the AmpG inner membrane permease, involved in the uptake of muropeptides (peptidoglycan degradation products) in *E. coli* ([@B25], [@B26]), is epistatic to the *nagA* phenotype until 24 h of growth. Intriguingly, the GlcNAc inner membrane transporter NagP is also epistatic to the *nagA* phenotype during the early stationary phase. This observation suggests either that NagP could transport muropeptides or that the release of GlcNAc from muropeptides during PG recycling takes place at least part in the periplasm. Based on our results, the outer membrane transporter NixC suppresses the sensitivity of the Δ*nagA* mutant during early stationary phase. Thus, this TBDT could be involved in the uptake of PG degradation products. To our knowledge, this is the first evidence of a transporter involved in the uptake of PG degradation products through the outer membrane.

*X. campestris* pv. *campestris* exploits chitooligosaccharides. {#h2.3}
----------------------------------------------------------------

*X. campestris* pv. *campestris* is an epiphytic bacterium that can live on leaf surfaces or as a saprophyte in necrotic tissues or in the ground ([@B14]). Thus, it could be in close proximity to and in competition with a large range of other microorganisms, like other bacteria or fungi, or even with insects. Therefore, although chitin is not a polymer produced by plants, it can be present in plant environments. *X. campestris* pv. *campestris* does not encode a chitinase, but chitin can be degraded into chitooligosaccharides by plant chitinases or by chitinases from chitinolytic microorganisms present in the plant environment. This work has shown that chitooligosaccharides are substrates of the *X. campestris* pv. *campestris* GlcNAc CUT system, with the TBDTs NixC and NixD being involved in the uptake of oligomers ranging from 2 to 6 GlcNAc residues, NixC being the major transporter for large oligomers (CHI-6). In *Caulobacter crescentus*, the TBDT encoded by *CC0446* is involved in the passive uptake of GlcNAc and in the active uptake of chitooligosaccharides ([@B6]). NixA, which seems not to be involved in the uptake of chitooligosaccharides, has the highest sequence identity with CC0446 (40.7%). However, phylogenetic analysis suggests that NixC (37.8% identity) is the ortholog of CC0446 (see [Fig. S2](#figS2){ref-type="supplementary-material"} in the supplemental material), which is in agreement with their role in uptake of chitooligosaccharides. The β-hexosaminidase NixG belonging to the *X. campestris* pv. *campestris* GlcNAc CUT system participates in the catabolism of chitooligosaccharides. Interestingly, the NixG ortholog in the *Xanthomonadaceae* member *Stenotrophomonas maltophilia* (Hex; 45.8% identity) was recently shown to be an exo-β-*N*-acetylhexosaminidase releasing GlcNAc from chitooligosaccharides up to hexamers ([@B34]). Growth of the Δ*nixE-nixL* strain on chitooligosaccharides was not abolished, suggesting that *X. campestris* pv. *campestris* encodes other β-*N*-acetylglucosaminidases that could degrade these substrates. In the carbohydrate-active enzyme database (CAZy; http://www.cazy.org), enzymes able to cleave GlcNAc residues can be found in classes EC 3.2.1.14 (chitinases; glycoside hydrolase families GH18, GH19, GH23, and GH48), EC 3.2.1.52 (β-*N*-acetylhexosaminidases; GH3, GH18, GH20, GH84, and GH116), and EC 3.2.1.96 (mannosyl-glycoprotein endo-β-*N*-acetylglucosaminidase; GH18, GH20, GH73, and GH85). Eighteen *X. campestris* pv. *campestris* proteins belong to these GH families, 3 of which (XCC2889, XCC2890, and XCC2892) are encoded by the *N*-glycan cluster. Further work is required to identify which *X. campestris* pv. *campestris* protein(s), not encoded by the *N*-glycan cluster, could participate in chitooligosaccharides utilization.

*N*-Glycans of *N*-glycoproteins: the plant source of GlcNAc? {#h2.4}
-------------------------------------------------------------

Based on the predicted enzymatic activities of the glycosides hydrolases NixE (XCC2888) to NixL (XCC2895), we propose that plant-derived GlcNAc-containing complex molecules metabolized by *X. campestris* pv. *campestris* during plant infection could be *N*-glycans from *N*-glycosylated proteins. Although the characterization of these enzymes is still under way, this cluster was named the *N*-glycan cluster. Epistasis experiments on the *nagA* phenotype *in planta* confirm the involvement of this cluster in the generation of GlcNAc during plant infection. Interestingly, epistasis experiments indirectly suggest that *nixD*, which is located in the same operon as the *N*-glycan cluster, codes for the major transporter of GlcNAc-containing molecules *in planta*, although NixA, -B, and -C also contribute to the uptake of these molecules during growth in XS. A proteomic study performed on *A. thaliana* stems revealed that most *N*-glycosylated proteins are predicted to have signal peptides, allowing secretion to the cell wall or plasma membrane ([@B35]). Furthermore, most of the proteins identified in the XS of *Brassica oleracea* cv. Bartolo F1 were secreted ([@B36]). Therefore, *N*-glycosylated proteins could be accessible to *X. campestris* pv. *campestris* during the infection process as constituents of the plant cell wall but also directly in XS. Compared to the huge amount of cell wall polysaccharides, *N*-glycans represent only a minor proportion of sugar polymers in plants ([@B37]). To exploit these molecules, bacteria must be able to recognize and transport them with high specificity and high affinity, which is in agreement with the involvement of active transporters such as TBDTs. Indeed, CUT systems, including degradative enzymes and active outer membrane transporters belonging to the TBDT family, were proposed to be devoted to the scavenging of scarce nutrients ([@B4]).

Among bacteria associated with plants, the *N*-glycan cluster is specific to *Xanthomonas* and *Xylella*. {#h2.5}
---------------------------------------------------------------------------------------------------------

A genome survey of bacteria associated with plants (pathogenic, symbiotic, and plant-associated bacteria) showed that the presence of the *N*-glycan cluster is a common feature of all *Xanthomonas* strains, whether these bacteria are vascular (*X. campestris* pv. *campestris*) or mesophyll (*X. campestris* pv. *vesicatoria*) pathogens (see [Table S5](#tabS5){ref-type="supplementary-material"} in the supplemental material). The cluster is also present in *Xanthomonas albilineans* and in *Xylella*, a xylem-restricted member of the *Xanthomonadaceae* closely related to *Xanthomonas* (see [Table S5](#tabS5){ref-type="supplementary-material"}). Both *X. albilineans* and *Xylella* displayed an important genome reduction ([@B38]). This shows the importance of this cluster for *Xanthomonas* and *Xylella* strains during their natural life cycle. Despite its high conservation among *Xanthomonas* and *Xylella* strains, the *N*-glycan cluster is absent in other phytopathogenic bacteria belonging to different genera (the α-proteobacterium *Agrobacterium*, the β-proteobacterium *Ralstonia solanacearum*, and the γ-proteobacteria *Dickeya dadantii*, *Erwinia amylovora*, and *Pseudomonas syringae*, for example), in nitrogen-fixing bacteria (such as *Sinorhizobium meliloti* and *Burkholderia phenoliruptrix*), and in plant growth-promoting or plant-associated bacteria (such as *Azospirillum caulinodans* and *Pseudomonas fluorescens*) (see [Table S5](#tabS5){ref-type="supplementary-material"}). This observation raises the question of the role of these proteins during plant infection.

Deglycosylation: only for feeding? {#h2.6}
----------------------------------

In the human pathogens *Streptococcus pneumoniae* and *Streptococcus oralis*, monosaccharides released during the sequential degradation of complex-type *N*-glycans from human glycoconjugates are used as a source of fermentable carbon ([@B39], [@B40]). Although the oligosaccharide moiety could be the nutrient source, *N*-glycan-degradative enzymes could also contribute to the accessibility of the peptide part of the glycoprotein to bacterial proteases, resulting in an optimized nutrient supply. Indeed, glycoproteins become more sensitive to proteases after deglycosylation of *N*-linked oligosaccharides ([@B41]). A role for the *X. campestris* pv. *campestris* GlcNAc utilization pathway might be to improve the access to amino acids as nutrients. Another possibility is that degradation of glycoprotein might lead to a weakening of the plant cell wall, leading to a better accessibility of plant cell wall polymers to degradative enzymes. Finally, this cluster could have an impact in signalization by activating or inactivating the function of proteins from the host. Indeed, in eukaryotes, glycosylation plays a crucial role in the proper folding of the protein and in intracellular trafficking related to cell surface expression ([@B42]). Glycosylations also regulate many physiological and pathological events, including cell growth ([@B43]), cell migration and cancer progression ([@B44], [@B45]), differentiation ([@B46]), plant cell wall synthesis ([@B47], [@B48]), and host-pathogen interactions ([@B49]), including PAMP (pathogen-associated molecular pattern) recognition by plant PRRs (pattern recognition receptors) ([@B50]). Further investigations are now being undertaken to decipher the role of the *N*-glycan cluster in *X. campestris* pv. *campestris* during the epiphytic life and the infection process and to characterize Nix enzymes*.*

MATERIALS AND METHODS {#h3}
=====================

Bacterial strains and growth conditions. {#h3.1}
----------------------------------------

The *X. campestris* pv. *campestris* strains and plasmids used in this study are listed in [Table S6](#tabS6){ref-type="supplementary-material"} in the supplemental material.

*X. campestris* pv. *campestris* cells were grown on MOKA rich medium ([@B4]), on MME minimal medium ([@B51]), or on MMC minimal medium \[Casamino Acids, 0.5 g/liter; K~2~HPO~4~, 10.5 g/liter; KH~2~PO~4~, 4.5 g/liter; MgSO~4~, 0.12 g/liter; (NH~4~)~2~SO~4~, 1 g/liter\] at 30°C. Antibiotics were used at 50 µg/ml for rifampin and kanamycin and 5 µg/ml for tetracycline. Pimaricin (30 µg/ml) was added to plates used for internal growth curves.

*E. coli* strains were grown on Luria-Bertani medium at 37°C. Antibiotics were used at 50 µg/ml for ampicillin and kanamycin, 10 µg/ml for tetracycline, and 40 µg/ml for spectinomycin.

Construction of *X. campestris* pv. *campestris* insertion and deletion mutants. {#h3.2}
--------------------------------------------------------------------------------

Insertion mutants were constructed using the suicide plasmid pVO155 ([@B52]) with \~300-bp PCR fragments internal to each open reading frame (see [Table S7](#tabS7){ref-type="supplementary-material"} in the supplemental material for primer pairs and [Table S6](#tabS6){ref-type="supplementary-material"} for insertion sites). Deletion mutants were constructed using the *sacB* system ([@B53]). We obtained amplicons of \~700 bp located upstream and downstream of the region to be deleted by PCR using specific primers (see [Table S7](#tabS7){ref-type="supplementary-material"}) and cloned them into the multiple cloning site (MCS) of pK18*mobsacB* plasmid. The sequences of all cloned PCR amplicons were verified by sequencing.

Plasmids obtained were introduced into *X. campestris* pv. *campestris* by triparental conjugation as described by Turner et al. ([@B54]). Insertions were verified by PCR using ProR (a pVO155-specific primer) and gene-specific seq1 primers (see [Table S7](#tabS7){ref-type="supplementary-material"} in the supplemental material). Deletions were verified by PCR using the left primer specific to the upstream fragment and the right primer specific to the downstream fragment used to amplify upstream and downstream amplicons, respectively (see [Table S7](#tabS7){ref-type="supplementary-material"}).

Complementation plasmid constructs. {#h3.3}
-----------------------------------

Genes corresponding to *nagA*, *nixF*, and *nixG* were PCR amplified using specific primers (see [Table S7](#tabS7){ref-type="supplementary-material"}). PCR amplicons were cloned into the MCS of complementation plasmids pCZ917 ([@B8]) or pCZ1016 ([@B9]) (see [Table S6](#tabS6){ref-type="supplementary-material"}) and verified by sequencing. Plasmids obtained were introduced into *X. campestris* pv. *campestris* by triparental conjugation.

Complementations by chromosomal insertions. {#h3.4}
-------------------------------------------

Genes corresponding to *nix* TBDTs and to the *nixE*-to-*nixL* cluster were PCR amplified using specific primers (see [Table S7](#tabS7){ref-type="supplementary-material"} in the supplemental material). PCR amplicons were cloned into the MCS of the pCZ1034 plasmid ([@B9]) under the control of the P~*tac*~ promoter and the T7 terminator. Plasmids obtained were introduced into *X. campestris* pv. *campestris* by triparental conjugation, and deletion of the *XCC0127*-to-*XCC0128* region combined with the insertion of the desired gene or region was achieved using the *sacB* protocol ([@B53]). Insertion of each gene was verified by PCR using the left primer specific to the upstream fragment and the right primer specific to the downstream fragment used to amplify upstream and downstream amplicons, respectively (see [Table S7](#tabS7){ref-type="supplementary-material"}).

qRT-PCR analysis. {#h3.5}
-----------------

Quantitative RT-PCR (qRT-PCR) was performed as previously described ([@B8]) (see [Table S7](#tabS7){ref-type="supplementary-material"} in the supplemental material for primers used). Briefly, cells were grown in MME minimal medium supplemented or not with GlcNAc at a final concentration of 10 mM and harvested by centrifugation when the optical density at 600 nm (OD~600~) was between 0.4 and 0.6. RNAs were extracted using the RNeasy minikit (Qiagen) and treated with RNase-free DNase I (Sigma) before being reverse transcribed by Superscript II (Invitrogen) using random hexamers (Biolabs). Quantitative-PCR amplification was performed on a Light Cycler (Roche). Experiments were carried out in three independent biological assays. As a control for real-time PCR, we used the 16S rRNA as previously described ([@B4], [@B55]) (see [Table S7](#tabS7){ref-type="supplementary-material"} in the supplemental material).

Calculation of maximal growth rate and population estimation, in CFU/ml. {#h3.6}
------------------------------------------------------------------------

*In vitro* growth curves were generated using the FLUOstar Omega apparatus (BMG Labtech, Offenburg, Germany) with four independent replicates. Growth rates were measured using 96-well flat-bottom microtiter plates containing 200 µl of MME minimal medium containing the desired substrate inoculated at an OD~600~ of 0.1 from 4 independent washed overnight precultures in MOKA rich medium. The microplates were shaken continuously at 700 rpm using the linear shaking mode. Specific maximal growth rate was calculated as described in reference [@B9].

To follow the *in vitro* bacterial populations, we determined the CFU per ml during bacterial growth. Cells from three independent washed overnight precultures in MOKA rich medium were inoculated at an OD~600~ of 0.1 in 2 ml MMC minimal medium containing the desired substrate in glass tubes at 30°C with shaking at 200 rpm. Growth experiments in XS were performed in a total volume of 350 µl in glass tubes. To limit dilution of XS, 17.5 µl of bacteria (OD~600~ = 0.2 in MMC) were added to 332.5 µl of XS, leading to an OD of 0.01 at time zero. CFU were quantified at various time points, by performing serial dilutions in sterile water before spotting 5 µl of these dilutions 3 times on rifampin-containing MOKA plates. After 48 h of growth at 30°C, colonies were enumerated in spots containing 1 to 30 colonies. Bacterial populations were calculated, and results are given in log CFU/ml.

Collection of cabbage xylem sap through root pressure. {#h3.7}
------------------------------------------------------

Xylem sap was collected from *Brassica oleracea* cv. Bartolo F1 cabbages as previously described ([@B56]). Briefly, XS was collected from 6- to 8-week-old plants after stem decapitation above the first true leaf pair. After the section had been rinsed thoroughly with distilled water, root pressure exudates (herein called XS) were collected throughout the day by manual pipetting. The two first harvests were discarded to avoid contamination by the remaining cell wall debris and phloem compounds. Fractions were frozen immediately after collection and stored at −20°C. For bacterial cultivation, XS was sterilized by filtration using 0.22 µM polytetrafluoroethylene (PTFE) filters.

Pathogenicity assays. {#h3.8}
---------------------

Pathogenicity assays were conducted on *Arabidopsis thaliana* ecotype Sf-2 by wound inoculation of the central vein as previously described ([@B4], [@B57]) using a bacterial inoculum with an OD~600~ of 0.05. Similarly, *Brassica oleracea* cv. Bartolo F1 cabbage leaves of 6-week-old plants were inoculated by piercing the central vein three times using a bacterial inoculum with an OD~600~ of 0.2. Disease development on *A. thaliana* leaves was scored at different days after inoculation using a disease index score (0, no symptoms; 1, faint chlorosis; 2, extended chlorosis; 3, necrosis; 4, leaf death). Results are given as percentages of the value for the reference strain.

The stability of pVO155 insertions during pathogenicity tests (8 days without selection pressure) was verified by analyzing the kanamycin resistance of 100 individual bacterial clones purified from leaf tissues 8 days postinoculation.

*In planta* internal growth curves (IGC). {#h3.9}
-----------------------------------------

To determine *in planta* bacterial population densities during infection, we obtained IGC. Twenty plants were inoculated, and symptoms were scored as described above. Each strain was tested in at least two independent experiments. For each sample, 3 inoculated leaf discs from 3 different plants were sampled using a cork borer (diameter, 0.65 cm; surface area, 0.33 cm^2^) at days 0, 1, 3, and 7 after inoculation and ground with beads in 500 µl of sterile water. The homogenates were serially diluted in sterile water, and 5-µl drops were spotted three times for each dilution (10^−1^ to 10^−6^) on MOKA plates supplemented with rifampin and pimaricin. Plates were incubated at 30°C for 48 h, and colonies were enumerated in spots containing 1 to 30 colonies. Bacterial densities in leaves were calculated, and values are reported in log CFU/cm^2^.

\[^14^C\]GlcNAc transport experiments. {#h3.10}
--------------------------------------

Transport experiments with radiolabeled GlcNAc (specific activity, 2.04 GBq/mmol; PerkinElmer) were performed as described previously ([@B4], [@B8]).

Bioinformatic analyses. {#h3.11}
-----------------------

The putative function of Nix glycoside hydrolases was examined using the carbohydrate-active enzyme database (CAZy; http://www.cazy.org/) and the KEGG pathway database (http://www.genome.jp/kegg/pathway.html).

Proteins belonging to the GlcNAc CUT system were sought in *Xanthomonas* and *Xylella* proteomes and in representative plant nitrogen-fixing, plant-associated, and plant-pathogenic bacterial proteomes using a BlastP search. Only bacteria with completely sequenced and assembled genomes (available genomes on 4 April 2014) were analyzed, and only proteins with at least 50% coverage and 30% identity or similarity were considered.

Phylogenetic analysis was performed using the Phylogeny.fr web server (http://www.phylogeny.fr/) in default mode ([@B58]).

SUPPLEMENTAL MATERIAL {#h4}
=====================

###### 

*X. campestris* pv. *campestris nixD* to *nixL* genes form an operon with a putative additional promoter upstream of *nixG*. (A) Schematic representation of the *nixE-nixL* cluster with arrowheads indicating pVO155 insertion sites. Light gray, insertion in *nixD* (*nixD*\*I mutant); white, insertion in *nixE* (*nixE*\*I mutant); dark gray, insertion in *nixG* (*nixG*\*I mutant); black, insertion in *nixI* (*nixI*\*I mutant). NagR boxes are represented by black circles. Black arrows indicate transcription start sites. (B to E) Expression of *nix* genes relative to the wt strain in *nixD*\*I (B), *nixE*\*I (C), *nixG*\*I (D), and *nixI*\*I (E) insertion mutants. Expressions were analyzed by qRT-PCR with at least three independent experiments on RNA extracted from strains grown in MME minimal medium supplemented with 10 mM *N*-acetylglucosamine. Calculation of relative expression includes normalization against the endogenous control gene 16S RNA. Download

###### 

Figure S1, EPS file, 0.1 MB

###### 

Neighbor-joining phylogenetic tree of *X. campestris* pv. *campestris* NixA, NixB, NixC, and NixD and *Caulobacter crescentus* CC0446 TonB-dependent transporters. This phylogenetic analysis was performed by using the Phylogeny.fr web server (<http://www.phylogeny.fr/>). The significance of each node was assessed by approximate-likelihood-ratio tests. Download

###### 

Figure S2, EPS file, 0.1 MB

###### 

Relative black rot symptom intensity, obtained for different strains of *X. campestris* pv. *campestris* on *Arabidopsis thaliana* ecotype Sf-2. Disease index was scored at 8 dpi and is presented as a percentage of the value for the wt strain, except in panel D, where disease index was given as percentage of the value for the *ampG*\*I mutant. (A) Disease index of single mutants and complemented strains. (B) Epistasis of the Δ*nagA* mutant. (C and D) Epistasis of the Δ*nagA ampG*\*I mutant.
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Table S1, XLSX file, 0.1 MB.

###### 

Epistasis during growth of *X. campestris* pv. *campestris* in MMC minimal medium containing chitohexaose (CHI-6) or in xylem sap (XS) of *Brassica oleracea* cv. Bartolo F1 cabbages. Results are given as maximal specific growth rates (µ~max~ \[h^−1^\]) relative to the wild-type (wt) strain. Specific μ~max~ were calculated from CFU counts during the log phase (between 3 and 9 h of growth). Standard deviations (SD) were obtained from at least 3 independent experiments. In red are values significantly different from those for the wt strain (sensitivity), in green are values significantly different from those for the Δ*nagA* strain (total epistasis), and in brown are values significantly different from those for both the wt and Δ*nagA* strains (partial epistasis), all with a *P* value of \<0.0001. nd, not determined.
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Table S2, XLSX file, 0.1 MB.

###### 

Epistasis during growth of *X. campestris* pv. *campestris* strains in MMC minimal medium containing *N***-**acetylglucosamine (GlcNAc) or chitotriose (CHI-3) at 100 µM. Results are given as maximal specific growth rates (µ~max~ \[h^−1^\]) relative to the wild-type (wt) strain. Specific µ~max~ were calculated from OD~600~ values during the log phase of the wt strain in MMC minimal medium containing GlcNAc (between 7 and 12 h of growth). Standard deviations (SD) were obtained from at least 3 independent experiments. In red are values significantly different from those for the wt strain (sensitivity), in green are values significantly different from those for the Δ*nagA* mutant (total epistasis), and in brown are values significantly different from those for both the wt and Δ*nagA* strains (partial epistasis), all with a *P* value of \<0.0001.

###### 

Table S3, XLSX file, 0.1 MB.

###### 

Growth of *X. campestris* pv. *campestris* strains MME minimal medium containing chitooligosaccharides. Results are given as maximal specific growth rates (µ~max~ in h^−1^) relative to the wild-type (wt) strain. Specific µ~max~ were calculated from OD~600~ values during the log phase of the wt in medium containing *N*-acetylglucosamine (GlcNAc) (between 7 and 12 h \[A\] or between 5 and 10 h \[B\] depending on the experiments). Substrates were added at a final concentration of 0.1% (wt/vol). Standard deviations (SD) were obtained from at least 3 independent experiments. Values underlined in gray indicate strains affected in growth compared to the wt strain, with a *P* value of \<0.0001. CHI-2, chitobiose; CHI-3, chitotriose; CHI-4, chitotetraose; CHI-5, chitopentaose; CHI-6, chitohexaose; CHI-n, chitin; nd, not determined.
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Table S4, XLSX file, 0.1 MB.

###### 

Conservation of genes belonging the *X. campestris* pv. *campestris* strain ATCC 33913 *N*-acetylglucosamine (GlcNAc) CUT system in sequenced and assembled genomes of *Xanthomonas* and *Xylella* strains and representative plant nitrogen-fixing, plant-associated, and plant-pathogenic bacteria.
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Table S5, XLSX file, 0.1 MB.

###### 

List of *X. campestris* pv. *campestris* strains and plasmids used or generated in this study.

###### 

Table S6, XLSX file, 0.1 MB.

###### 

List of primers used in this study. Sequences corresponding to restriction sites are underlined and sequences nonhomologous to *X. campestris* pv. *campestris* are in italics.

###### 

Table S7, XLSX file, 0.1 MB.
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